{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:16:57Z","timestamp":1758817017519},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf01259344","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T21:36:50Z","timestamp":1111613810000},"page":"45-54","source":"Crossref","is-referenced-by-count":6,"title":["Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism"],"prefix":"10.1007","volume":"64","author":[{"given":"H.","family":"Baas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. -A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Japp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"303","volume-title":"Pathophysiologie, Klinik und Therapie des Parkinsonismus","author":"H. Baas","year":"1983","unstructured":"Baas, H., Schneider, E., Fischer, P.-A.: CU 32-085 versus Bromocriptin in der Kombinationstherapie beim Parkinson-Syndrom. In: Pathophysiologie, Klinik und Therapie des Parkinsonismus (G\u00e4nshirt, H., ed.), pp. 303?308. Basel-Grenzach-Wyhlen: Editiones Roche. 1983."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00313593","volume":"230","author":"H. Biesemeyer","year":"1983","unstructured":"Biesemeyer, H., Ludin, H. P., Ringwald, E.: Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease. J. Neurol.230, 19?23 (1983).","journal-title":"J. Neurol."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/0024-3205(81)90494-X","volume":"29","author":"A. Enz","year":"1981","unstructured":"Enz, A.: Biphasic influence of a 8-alpha-amino-ergoline, CU 32-085, on striatal dopamine synthesis and turnoverin vivo in the rat. Life Sci.29, 2227?2234 (1981).","journal-title":"Life Sci."},{"key":"CR4","unstructured":"Enz, A., Frick, W., Cosse, A., Nordmann, R.: Dopaminergic properties of CU 32-085 and its 1,20-N, N-bidemethylated metabolite. In: Abstracts of the 13 th CINP Congress, Jerusalem 1978, Vol. 1, A-N., p. 199. Collegium Internationale Neuro-Psychopharmacologicum (1982)."},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"Enz, A., Donatsch, P., Nordmann, R.: Dopaminergic properties of mesulergine (CU 32-085) and its metabolites. J. Neural. Transm. In press (1985 a).","DOI":"10.1007\/BF01249095"},{"key":"CR6","volume-title":"Proceedings 1. European Congr. Neuroend. Assoc","author":"A. Enz","year":"1985","unstructured":"Enz, A., Donatsch, P., Briner, U., Jaton, A. L., Markstein, R., Palacios, J. M.: Dopaminergic profile of mesulergine. In: Proceedings 1. European Congr. Neuroend. Assoc. (Marsden, C. D., Calne, D. B., Lataste, X., eds.). London-Oxford: Academic Press. In press (1985b)."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/BF01953267","volume":"35","author":"E. Fl\u00fcckiger","year":"1979","unstructured":"Fl\u00fcckiger, E., Briner, U., B\u00fcrki, H. R., Marbach, P., Wagner, H. R., Doepfner, W.: Two novel prolactoin release-inhibiting B-alpha-amino-ergolines. Experientia35, 1677?1678 (1979).","journal-title":"Experientia"},{"key":"CR8","first-page":"67","volume":"53","author":"E. Ringwald","year":"1982","unstructured":"Ringwald, E., Hirt, D., Markstein, R., Vigouret, J. M.: Dopaminrezeptorenstimulatoren in der Behandlung der Parkinsonkrankheit. Nervenarzt53, 67?71 (1982).","journal-title":"Nervenarzt"},{"key":"CR9","first-page":"431","volume-title":"Lisuride and Other Dopamine Agonists","author":"U. K. Rinne","year":"1983","unstructured":"Rinne, U. K.: New ergot derivatives in the treatment of Parkinson's disease. In: Lisuride and Other Dopamine Agonists (Calne, D. B., Horowski, R., McDonald, R. J., Wuttke, W., eds.), pp. 431?442. New York: Raven Press. 1983."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00313415","volume":"228","author":"E. Schneider","year":"1982","unstructured":"Schneider, E., Fischer, P.-A.: Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment. J. Neurol.228, 249?258 (1982).","journal-title":"J. Neurol."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.33.4.468","volume":"33","author":"E. Schneider","year":"1983","unstructured":"Schneider, E., Hubener, K., Fischer, P.-A.: Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085. Neurology (Cleveland)33, 462?472 (1983).","journal-title":"Neurology (Cleveland)"},{"key":"CR12","first-page":"527","volume-title":"Adv. Neurol. Vol. 40","author":"E. Schneider","year":"1984","unstructured":"Schneider, E., Hubener, K., Fischer, P.-A.: Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients. (Adv. Neurol. Vol. 40) (Hassler, R. G., Christ, J. F., eds.), pp. 527?529. New York: Raven Press. 1984."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00314036","volume":"232","author":"E. Schneider","year":"1984","unstructured":"Schneider, E., Baas, H., Fischer, P.-A., Hopp, G.: Long-term effects of mesulergine (CU 32-085) in advanced and de novo parkinsonian patients. Results of a 3 year's observation. J. Neurol.232, 24?29 (1984b).","journal-title":"J. Neurol."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1212\/WNL.35.1.83","volume":"35","author":"H. Ter\u00e4v\u00e4inen","year":"1985","unstructured":"Ter\u00e4v\u00e4inen, H., Huttunen, J., Hietanen, M.: Initial treatment of parkinsonism with 8-alpha-amino-ergoline. Neurology35, 83?88 (1985).","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01259344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01259344\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01259344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T12:36:04Z","timestamp":1586176564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01259344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF01259344"],"URL":"https:\/\/doi.org\/10.1007\/bf01259344","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}